JRCT ID: jRCT2080220289
Registered date:07/08/2006
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Type 2 Diabetes Mellitus |
Date of first enrollment | 07/08/2006 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : MK-0431/ONO-5435 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Efficacy, Safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | The target population is the outpatients >=20 years of age with type 2 diabetes mellitus (male and female) who have inadequate glycemic control on diet/exercise therapy. |
Exclude criteria |
Related Information
Primary Sponsor | ONO PHARMACEUTICAL CO.,LTD. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-060294 |
Contact
Public contact | |
Name | |
Address | 06-6263-5670 |
Telephone | |
Affiliation | Ono Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |